![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
YA Kolesnikov, S Jain, R Wilson and GW Pasternak
Cotzias Laboratory of Neuro-Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Morphine injected s.c. in the tail is a potent analgesic in the tail- flick assay when the radiant heat source is focused directly over the injection site (ED50, 4.5 micrograms), but not if the radiant heat source is moved 1 cm proximally or distally to the injection site. Naloxone given systemically reverses this peripheral analgesia. Antisense oligodeoxynucleotides directed against exons 1 and 4 of MOR- 1, a cloned mu opioid receptor, administered intrathecally (i.t.) block the local analgesic effect of morphine in the tail, indicating that the local response is mediated through mu receptors located on the terminals of sensory neurons from the dorsal root ganglia. Combinations of morphine given locally in the tail and spinally (i.t.) are synergistic. Spinal morphine also synergizes with systemic morphine in analgesia assays. Supraspinal morphine enhances systemic morphine analgesia, but less dramatically. We also examined tolerance on these analgesic systems by using a daily morphine injection paradigm which shifts the dose-response curve for systemic morphine approximately 2- fold after 5 days. In this paradigm, morphine's analgesic potency after either supraspinal or spinal administration alone does not change. However, the dose-response curve for local morphine in the tail is shifted by over 19-fold. The analgesic activity of the combination of supraspinal and systemic morphine is lowered approximately 2-fold and the combination of i.t. and systemic morphine by 12-fold. These studies confirm the presence of a peripheral mechanism for morphine analgesia mediated by mu receptors located on sensory neurons from the dorsal root ganglia, which is extremely sensitive to chronic morphine dosing.
This article has been cited by other articles:
|
|
 |
|
  Y. Ji, A. Z. Murphy, and R. J. Traub Sex differences in morphine-induced analgesia of visceral pain are supraspinally and peripherally mediated Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R307 - R314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Walwyn, N. T. Maidment, M. Sanders, C. J. Evans, B. L. Kieffer, and T. G. Hales Induction of {delta} Opioid Receptor Function by Up-Regulation of Membrane Receptors in Mouse Primary Afferent Neurons Mol. Pharmacol., December 1, 2005; 68(6): 1688 - 1698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Furst, P. Riba, T. Friedmann, J. Timar, M. Al-Khrasani, I. Obara, W. Makuch, M. Spetea, J. Schutz, R. Przewlocki, et al. Peripheral versus Central Antinociceptive Actions of 6-Amino Acid-Substituted Derivatives of 14-O-Methyloxymorphone in Acute and Inflammatory Pain in the Rat J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 609 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. A. Kolesnikov, R. S. Wilson, and G. W. Pasternak The Synergistic Analgesic Interactions Between Hydrocodone and Ibuprofen Anesth. Analg., December 1, 2003; 97(6): 1721 - 1723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Meuser, T. Giesecke, A. Gabriel, M. Horsch, R. Sabatowski, J. Hescheler, S. Grond, and P. P. Palmer Mu-Opioid Receptor mRNA Regulation During Morphine Tolerance in the Rat Peripheral Nervous System Anesth. Analg., November 1, 2003; 97(5): 1458 - 1463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. A. Kolesnikov, M. Cristea, and G. W. Pasternak Analgesic Synergy Between Topical Morphine and Butamben in Mice Anesth. Analg., October 1, 2003; 97(4): 1103 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Tegeder, S. Meier, M. Burian, H. Schmidt, G. Geisslinger, and J. Lotsch Peripheral opioid analgesia in experimental human pain models Brain, May 1, 2003; 126(5): 1092 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Bolan, R. J. Tallarida, and G. W. Pasternak Synergy between {micro} Opioid Ligands: Evidence for Functional Interactions among {micro} Opioid Receptor Subtypes J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 557 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Mogil and G. W. Pasternak The Molecular and Behavioral Pharmacology of the Orphanin FQ/Nociceptin Peptide and Receptor Family Pharmacol. Rev., September 1, 2001; 53(3): 381 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. A. Kolesnikov, I. Chereshnev, and G. W. Pasternak Analgesic Synergy between Topical Lidocaine and Topical Opioids J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 546 - 551. [Abstract] [Full Text]
|
|
|
|
|
|
C. K. Nielsen, F. B. Ross, and M. T. Smith Incomplete, Asymmetric, and Route-Dependent Cross-Tolerance between Oxycodone and Morphine in the Dark Agouti Rat J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 91 - 99. [Abstract] [Full Text]
|
|
|
|
|
|
M. Inoue and H. Ueda Protein Kinase C-Mediated Acute Tolerance to Peripheral {micro}-Opioid Analgesia in the Bradykinin-Nociception Test in Mice J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 662 - 669. [Abstract] [Full Text]
|
|
|
|
|
|
C. M. Palmer, W. M. Nogami, G. Van Maren, and D. M. Alves Postcesarean Epidural Morphine: A Dose-Response Study Anesth. Analg., April 1, 2000; 90(4): 887 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-X. Pan, J. Xu, E. Bolan, C. Abbadie, A. Chang, A. Zuckerman, G. Rossi, and G. W. Pasternak Identification and Characterization of Three New Alternatively Spliced {micro}-Opioid Receptor Isoforms Mol. Pharmacol., August 1, 1999; 56(2): 396 - 403. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Kolesnikov and G. W. Pasternak Topical Opioids in Mice: Analgesia and Reversal of Tolerance by a Topical N-Methyl-D-Aspartate Antagonist J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 247 - 252. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. W. Pasternak The central questions in pain perception may be peripheral PNAS, September 1, 1998; 95(18): 10354 - 10355. [Full Text] [PDF]
|
|
|
|
 |
|
 K. O. Aley and J. D. Levine Different Mechanisms Mediate Development and Expression of Tolerance and Dependence for Peripheral µ-Opioid Antinociception in Rat J. Neurosci., October 15, 1997; 17(20): 8018 - 8023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Brown, K. Yang, O. Ouerfelli, K. M. Standifer, D. Byrd, and G. W. Pasternak 3H-Morphine-6beta -Glucuronide Binding in Brain Membranes and an MOR-1-Transfected Cell Line J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1291 - 1297. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
